跳转至内容
Merck
  • Stability enhanced polyelectrolyte-coated gold nanorod-photosensitizer complexes for high/low power density photodynamic therapy.

Stability enhanced polyelectrolyte-coated gold nanorod-photosensitizer complexes for high/low power density photodynamic therapy.

Biomaterials (2014-05-27)
Zhenzhi Shi, Wenzhi Ren, An Gong, Xinmei Zhao, Yuehong Zou, Eric Michael Bratsolias Brown, Xiaoyuan Chen, Aiguo Wu
摘要

Photodynamic therapy (PDT) is a promising treatment modality for cancer and other malignant diseases, however safety and efficacy improvements are required before it reaches its full potential and wider clinical use. Herein, we investigated a highly efficient and safe photodynamic therapy procedure by developing a high/low power density photodynamic therapy mode (high/low PDT mode) using methoxypoly(ethylene glycol) thiol (mPEG-SH) modified gold nanorod (GNR)-AlPcS4 photosensitizer complexes. mPEG-SH conjugated to the surface of simple polyelectrolyte-coated GNRs was verified using Fourier transform infrared spectroscopy; this improved stability, reduced cytotoxicity, and increased the encapsulation and loading efficiency of the nanoparticle dispersions. The GNR-photosensitizer complexes were exposed to the high/low PDT mode (high light dose = 80 mW/cm(2) for 0.5 min; low light dose = 25 mW/cm(2) for 1.5 min), and a high PDT efficacy leads to approximately 90% tumor cell killing. Due to synergistic plasmonic photothermal properties of the complexes, the high/low PDT mode demonstrated improved efficacy over using single wavelength continuous laser irradiation. Additionally, no significant loss in viability was observed in cells exposed to free AlPcS4 photosensitizer under the same irradiation conditions. Consequently, free AlPcS4 released from GNRs prior to cellular entry did not contribute to cytotoxicity of normal cells or impose limitations on the use of the high power density laser. This high/low PDT mode may effectively lead to a safer and more efficient photodynamic therapy for superficial tumors.

材料
货号
品牌
产品描述

Sigma-Aldrich
硼氢化钠, powder, ≥98.0%
Sigma-Aldrich
溴化十六烷基三甲铵, ≥98%
Sigma-Aldrich
L -抗坏血酸, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
硼氢化钠, ReagentPlus®, 99%
Sigma-Aldrich
溴化十六烷基三甲铵, for molecular biology, ≥99%
Sigma-Aldrich
L -抗坏血酸, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
链霉素 硫酸盐, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
L -抗坏血酸, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
溴化十六烷基三甲铵, BioXtra, ≥99%
Sigma-Aldrich
L -抗坏血酸, reagent grade, crystalline
Sigma-Aldrich
L -抗坏血酸, 99%
USP
抗坏血酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
硼氢化钠, granular, 99.99% trace metals basis
Supelco
L -抗坏血酸, analytical standard
Supelco
维生素C, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L -抗坏血酸, reagent grade
Sigma-Aldrich
L -抗坏血酸, ACS reagent, ≥99%
Sigma-Aldrich
硼氢化钠, purum p.a., ≥96% (gas-volumetric)
Sigma-Aldrich
溴化十六烷基三甲铵, BioUltra, for molecular biology, ≥99.0% (AT)
Sigma-Aldrich
L -抗坏血酸, meets USP testing specifications
Sigma-Aldrich
链霉素 硫酸盐, powder
Sigma-Aldrich
L -抗坏血酸, FCC, FG
Sigma-Aldrich
硼氢化钠 溶液, ~12 wt. % in 14 M NaOH
Sigma-Aldrich
链霉素 硫酸盐, powder, BioXtra, suitable for mouse embryo cell culture
Sigma-Aldrich
L -抗坏血酸, BioUltra, ≥99.5% (RT)
Sigma-Aldrich
硼氢化钠, granular, 10-40 mesh, 98%
Sigma-Aldrich
L -抗坏血酸, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)
Sigma-Aldrich
溴化十六烷基三甲铵, ≥96.0% (AT)
Sigma-Aldrich
硼氢化钠, caplets (18 × 10 × 8 mm), 98%
Sigma-Aldrich
硼氢化钠 溶液, 2.0 M in triethylene glycol dimethyl ether